Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consort Medical First Half Profit Falls Due To Cramlington Incident

Tue, 03rd Dec 2019 09:14

(Alliance News) - Consort Medical PLC on Tuesday said its interim profit was considerably smaller following an incident at its Aesica Cramlington manufacturing facility.

Consort's pretax profit for the six months ended October 31 was GBP1.2 million, far less than the GBP9.6 million profit posted the year before as revenue fell 4.3% to GBP146.0 million from GBP152.5 million.

This was primarily caused by the Cramlington incident, in which a small area of the Northumberland-based operating plant was damaged in what was described by Consort at the time as "the rapid thermal degradation of a chemical resulting in the expulsion of material and contamination of the facility".

This hurt the performance of its active pharmaceutical ingredients and finished dose manufacturing unit, Aesica, where revenue fell 11% to GBP81.1 million from GBP90.9 million.

Bespak, Consort's drug delivery devices unit, was unaffected, with revenue up 5.4% at GBP64.9 million versus GBP61.6 million the year prior.

On November 18, following the end of its first half, contract development and manufacturing pharmaceutical company Consort agreed to a GBP505 million bid from Swedish peer Recipharm AB. Recipharm will pay 1,010 pence in cash for each Consort share. The proposed deal implies an enterprise value of GBP627 million for Consort.

Given that Recipharm may reduce its acquisition consideration if any dividend or other distribution is made by the Hemel Hempstead-based company, Consort has opted not to declare an interim dividend.

Consort Chief Executive Jonathan Glenn said: "The board's expectations for the full year remain unchanged. We anticipate that the group's performance in the second half of the year will benefit from continued growth in Bespak, recommencing manufacture of the specific product involved in the Cramlington incident and a reduction in the backlog at Aesica.

"The group is subject to a recommended offer from Recipharm Holdings Ltd. The board remains confident of Consort's future prospects."

Shares in Consort were down 0.5% at 1,040.00 pence in London on Tuesday morning.

By Anna Farley; annafarley@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
16 Oct 2014 08:57

Thursday broker round-up UPDATE

Afren: Investec cuts target price from 195p to 120p and reiterates its hold recommendation. Amerisur Resources: Investec lowers target price from 75p to 65p and maintains a buy recommendation. Antofagasta: UBS upgrades from sell to neutral with a target price of 710p. ARM Holdings: Credit Suisse r

Read more
16 Oct 2014 07:16

UK MORNING BRIEFING: Shares Stage Rebound, But Not Jilted Shire

Read more
16 Oct 2014 05:16

UK AGM, EGM Calendar - Week Ahead

Read more
15 Oct 2014 15:07

UK AGM, EGM Calendar - Week Ahead

Read more
15 Oct 2014 05:23

UK AGM, EGM Calendar - Week Ahead

Read more
14 Oct 2014 15:27

UK AGM, EGM Calendar - Week Ahead

Read more
14 Oct 2014 05:22

UK AGM, EGM Calendar - Week Ahead

Read more
13 Oct 2014 14:57

UK AGM, EGM Calendar - Week Ahead

Read more
13 Oct 2014 05:30

UK AGM, EGM Calendar - Week Ahead

Read more
10 Oct 2014 14:48

UK AGM, EGM Calendar - Week Ahead

Read more
10 Oct 2014 05:26

UK AGM, EGM Calendar - Week Ahead

Read more
9 Oct 2014 15:15

UK AGM, EGM Calendar - Week Ahead

Read more
9 Oct 2014 09:27

Thursday broker round-up UPDATE

African Barrick Gold: Numis reduces target price from 330p to 270p keeping its hold recommendation. Antofagasta: Numis upgrades to hold with a target price of 700p. Aureus Mining: Numis lowers target price from 45p to 40p staying with its buy recommendation. Boohoo: Barclays initiates with a targe

Read more
2 Oct 2014 10:11

Thursday broker round-up UPDATE

BAE Systems: Investec downgrades from hold to sell with a target price of 430p. British Sky Broadcasting: Credit Suisse ups target price from 600p to 630p and reiterates an underperform rating. Cobham: Investec lowers target price from 290p to 280p and stays with its reduce rating. Consort Medical

Read more
30 Sep 2014 09:50

Tuesday broker round-up UPDATE

Aberdeen: Goldman Sachs ups target price from 540p to 560pp retaining a buy recommendation. African Barrick Gold: Deutsche Bank moves target price from 270p to 280p and reiterates a hold recommendation. Investec lowers target price from 260p to 258p, while upgrading to buy. African Minerals: Invest

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.